Saving Sight: Cleveland Clinic Ohio Ophthalmology Webcast

CME/CE 

This accredited activity is jointly provided by Partners for Advancing Clinical Education (Partners) and DKBmed.​​ 

Acknowledgement 

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. 

All activity content and materials are developed solely by the planning committee members and faculty presenters. 

Target Audience 

The target audience includes ophthalmologists and retina specialists attending the live and enduring education with a focus on the Midwest.

Educational Objectives 

Upon completion of this activity, participants should be able to:  

  • Discuss consequences of delayed treatment of neovascular AMD.  
  • Discuss consequences of delayed treatment of diabetic retinopathy.  
  • Describe efficacy and safety of newer anti-VEGF treatments for nAMD.  
  • Evaluate the benefits of newly available treatment anti-VEGF options for DR and DME.  

Disclosures 

Partners requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.  

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.  

Faculty / Presenter Reported Financial Relationship 

Faculty Conflicts of Interest
Dr. Sumit Sharma, MD​

Cleveland Clinic​
Cole Eye Institute​
Assistant Professor of Ophthalmology​
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University 		Consultant, Advisor, Speaker: Alimera, Abbvie, Apellis, Bausch and Lomb, Clearside, Eyepoint, Genentech/Roche, Iveric Bio, Kodiak, Merck, Regeneron, RegenXBio, Ripple, Volk, Zeiss 
Researcher: ​​Acelyrin, Gilead, Genentech/Roche, Santen, IONIS, Kodiak 

Joint Accreditation Statement 

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and DKBmed LLC. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Education 

Partners designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.​ 

Disclosure of Unlabeled Use 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.  

Disclaimer 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.  

There are no fees for participating and receiving CME/CE credit for this activity.  

Request for Credit 

If you wish to receive acknowledgment for completing this live activity, please complete the evaluation.  

  • Release date: April 8, 2026  
  • Expiration date: TBD  

 Estimated time to complete the activity: 60 minutes  

Hardware & Software Requirements 

To access activities, users will need:   

  • A computer with an internet connection   
  • An HTML5 compliant web browser or Internet Explorer 8 (and higher)   

Contact Information 

For additional information about the accreditation of this activity, please visit https://partnersed.com